Synergy of LCL161, an antagonist of inhibitor of apoptosis proteins (IAPs), with paclitaxel in a gene expression signature-enriched cohort of triple-negative breast cancer (TNBC)
Date issued
2015Journal title
EUROPEAN JOURNAL OF CANCER
Type of content
Publicación de congreso